To view or add a comment, sign in Beyond Weight Loss: The New Era of Obesity Medicine with Triple-Agonists and Complication-Centric Care The landscape of obesity medicine is transforming at an unprecedented pace
When peripheral nerves get wounded, the myelin structures of Schwann cells (SCs) dedifferentiate and begin the regeneration process (Gaudet et al., 2011)
They come in a solid dosage form and are stored in a dry place
This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Disease
Another trial investigating exenatide (another GLP-1 agonist) also found reduced alcohol consumption and improved metabolic health outcomes (Goudriaan et al., 2022)